硬化症-话题@MedSci

#硬化症#

413篇内容 | 2648人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1983097, encodeId=6268198309e99, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：多发性硬化症患者多重死亡原因分析, objectType=article, longId=186291, objectId=99f918629103, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99f918629103, replyNumber=0, likeNumber=105, createdTime=2020-07-23, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99f918629103, moduleTitle=Neurology：多发性硬化症患者多重死亡原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99f918629103)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983119, encodeId=6ee2198311930, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Ann Rheum Dis：系统性硬化症自体造血干细胞移植后死亡和主要不良事件的预测因素, objectType=article, longId=194229, objectId=ac201942299a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac201942299a, replyNumber=0, likeNumber=116, createdTime=2020-08-25, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac201942299a, moduleTitle=Ann Rheum Dis：系统性硬化症自体造血干细胞移植后死亡和主要不良事件的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac201942299a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983080, encodeId=ea1d1983080cd, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Ann Neurol：端粒长度与多发性硬化症的残疾进展有关, objectType=article, longId=179307, objectId=f9301e930794, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9301e930794, replyNumber=0, likeNumber=98, createdTime=2019-12-03, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9301e930794, moduleTitle=Ann Neurol：端粒长度与多发性硬化症的残疾进展有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9301e930794)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983120, encodeId=4e25198312056, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=EAN 2020：BTK抑制剂Evobrutinib治疗复发性多发性硬化症的有效性和安全性良好, objectType=article, longId=194711, objectId=2e1a194e1115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e1a194e1115, replyNumber=0, likeNumber=73, createdTime=2020-10-11, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e1a194e1115, moduleTitle=EAN 2020：BTK抑制剂Evobrutinib治疗复发性多发性硬化症的有效性和安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e1a194e1115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983100, encodeId=a7f719831009f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Nintedanib治疗系统性硬化症相关性间质性肺病：已获得CHMP的积极评价, objectType=article, longId=189088, objectId=39b718908848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39b718908848, replyNumber=0, likeNumber=85, createdTime=2020-03-24, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39b718908848, moduleTitle=Nintedanib治疗系统性硬化症相关性间质性肺病：已获得CHMP的积极评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39b718908848)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983112, encodeId=5c40198311288, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=PNAS：熊果酸逆转多发性硬化症中的神经元损伤, objectType=article, longId=192085, objectId=143c192085fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=143c192085fb, replyNumber=0, likeNumber=89, createdTime=2020-05-12, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=143c192085fb, moduleTitle=PNAS：熊果酸逆转多发性硬化症中的神经元损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=143c192085fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983085, encodeId=e51b198308584, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：儿童和成人发病的多发性硬化症患者生活质量的决定因素, objectType=article, longId=183123, objectId=216a18312397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=216a18312397, replyNumber=0, likeNumber=83, createdTime=2020-10-03, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=216a18312397, moduleTitle=Neurology：儿童和成人发病的多发性硬化症患者生活质量的决定因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=216a18312397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983070, encodeId=d3d419830e0cf, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=FDA驳回了Biohaven舌下制剂治疗肌萎缩侧索硬化症, objectType=article, longId=175938, objectId=450e1e5938bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=450e1e5938bf, replyNumber=0, likeNumber=85, createdTime=2020-05-02, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=450e1e5938bf, moduleTitle=FDA驳回了Biohaven舌下制剂治疗肌萎缩侧索硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=450e1e5938bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983074, encodeId=f0d819830e4fc, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Nature：多发性硬化症患者大脑的疾病根源——投射神经元, objectType=article, longId=177182, objectId=6ca51e7182eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ca51e7182eb, replyNumber=0, likeNumber=61, createdTime=2020-04-28, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca51e7182eb, moduleTitle=Nature：多发性硬化症患者大脑的疾病根源——投射神经元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ca51e7182eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983091, encodeId=9fec19830917c, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=FDA批准了诺华多发性硬化症药物Gilenya的仿制药, objectType=article, longId=184300, objectId=0ae61843008b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ae61843008b, replyNumber=0, likeNumber=65, createdTime=2020-02-09, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ae61843008b, moduleTitle=FDA批准了诺华多发性硬化症药物Gilenya的仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ae61843008b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983092, encodeId=c6ba1983092b5, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=多发性硬化症极易误诊，身体出现这些症状需要注意啦！, objectType=article, longId=184352, objectId=962d18435259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=962d18435259, replyNumber=0, likeNumber=74, createdTime=2020-02-26, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=962d18435259, moduleTitle=多发性硬化症极易误诊，身体出现这些症状需要注意啦！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=962d18435259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983113, encodeId=b0401983113c4, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Rheumatol：肾脏抵抗指数，用于随访系统性硬化症血管改变的新型生物标志物, objectType=article, longId=192088, objectId=224b192088c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=224b192088c0, replyNumber=0, likeNumber=87, createdTime=2020-06-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=224b192088c0, moduleTitle=J Rheumatol：肾脏抵抗指数，用于随访系统性硬化症血管改变的新型生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=224b192088c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983099, encodeId=44c3198309929, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=复发性多发性硬化症（MS）的治疗再迎进展：BTK抑制剂SAR442168达到中期研究的主要终点, objectType=article, longId=187657, objectId=c23618e6572f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c23618e6572f, replyNumber=0, likeNumber=64, createdTime=2020-11-12, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c23618e6572f, moduleTitle=复发性多发性硬化症（MS）的治疗再迎进展：BTK抑制剂SAR442168达到中期研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c23618e6572f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983109, encodeId=e0b2198310917, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Arthritis Rheumatol：血浆血管生物标志物在系统性硬化症中的有效性, objectType=article, longId=191089, objectId=dec6191089fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec6191089fa, replyNumber=0, likeNumber=72, createdTime=2020-11-08, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec6191089fa, moduleTitle=Arthritis Rheumatol：血浆血管生物标志物在系统性硬化症中的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec6191089fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983093, encodeId=6d3319830933d, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Ann Rheum Dis：系统性硬化症的血流动力学表型和生存率, objectType=article, longId=184519, objectId=dec318451941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec318451941, replyNumber=0, likeNumber=63, createdTime=2020-09-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec318451941, moduleTitle=Ann Rheum Dis：系统性硬化症的血流动力学表型和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec318451941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983090, encodeId=faac1983090cd, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：血浆多不饱和脂肪酸与肌萎缩性侧索硬化症的风险, objectType=article, longId=184172, objectId=5a091841e218, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a091841e218, replyNumber=0, likeNumber=63, createdTime=2020-04-09, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a091841e218, moduleTitle=Neurology：血浆多不饱和脂肪酸与肌萎缩性侧索硬化症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a091841e218)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983068, encodeId=3aff19830688a, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Arthritis Rheumatol：肺蛋白KL-6和CCL-18可以预测系统性硬化症间质性肺病的进展, objectType=article, longId=172151, objectId=f31f1e215182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f31f1e215182, replyNumber=0, likeNumber=69, createdTime=2019-09-07, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f31f1e215182, moduleTitle=Arthritis Rheumatol：肺蛋白KL-6和CCL-18可以预测系统性硬化症间质性肺病的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f31f1e215182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983096, encodeId=5a571983096a5, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=JEM：南医大新发现罕见病多发性硬化症的一个致病蛋白, objectType=article, longId=185456, objectId=588d1854564f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=588d1854564f, replyNumber=0, likeNumber=57, createdTime=2020-01-28, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=588d1854564f, moduleTitle=JEM：南医大新发现罕见病多发性硬化症的一个致病蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=588d1854564f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983088, encodeId=31b01983088d2, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Arthritis Rheumatol：使用自身抗体和皮肤亚群建立系统性硬化症基于结局的疾病分类, objectType=article, longId=183574, objectId=4d701835e4cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d701835e4cb, replyNumber=0, likeNumber=61, createdTime=2020-07-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d701835e4cb, moduleTitle=Arthritis Rheumatol：使用自身抗体和皮肤亚群建立系统性硬化症基于结局的疾病分类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d701835e4cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1983062, encodeId=8ff41983062b1, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=返老还童？——系统性硬化症, objectType=article, longId=165791, objectId=e04f165e9123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e04f165e9123, replyNumber=0, likeNumber=86, createdTime=2020-03-22, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e04f165e9123, moduleTitle=返老还童？——系统性硬化症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e04f165e9123)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

硬化症

2020-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：多发性硬化症患者多重死亡原因分析

2020-07-23

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Ann Rheum Dis：系统性硬化症自体造血干细胞移植后死亡和主要不良事件的预测因素

2020-08-25

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Ann Neurol：端粒长度与多发性硬化症的残疾进展有关

2019-12-03

30397604 (审核中...)

前往app查看评论内容

#硬化症#

EAN 2020：BTK抑制剂Evobrutinib治疗复发性多发性硬化症的有效性和安全性良好

2020-10-11

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Nintedanib治疗系统性硬化症相关性间质性肺病：已获得CHMP的积极评价

2020-03-24

30397604 (审核中...)

前往app查看评论内容

#硬化症#

PNAS：熊果酸逆转多发性硬化症中的神经元损伤

2020-05-12

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：儿童和成人发病的多发性硬化症患者生活质量的决定因素

2020-10-03

30397604 (审核中...)

前往app查看评论内容

#硬化症#

FDA驳回了Biohaven舌下制剂治疗肌萎缩侧索硬化症

2020-05-02

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Nature：多发性硬化症患者大脑的疾病根源——投射神经元

2020-04-28

30397604 (审核中...)

前往app查看评论内容

#硬化症#

FDA批准了诺华多发性硬化症药物Gilenya的仿制药

2020-02-09

30397604 (审核中...)

前往app查看评论内容

#硬化症#

多发性硬化症极易误诊，身体出现这些症状需要注意啦！

2020-02-26

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Rheumatol：肾脏抵抗指数，用于随访系统性硬化症血管改变的新型生物标志物

2020-06-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

复发性多发性硬化症（MS）的治疗再迎进展：BTK抑制剂SAR442168达到中期研究的主要终点

2020-11-12

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Arthritis Rheumatol：血浆血管生物标志物在系统性硬化症中的有效性

2020-11-08

hb2008ye (审核中...)

前往app查看评论内容

#硬化症#

Ann Rheum Dis：系统性硬化症的血流动力学表型和生存率

2020-09-12

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：血浆多不饱和脂肪酸与肌萎缩性侧索硬化症的风险

2020-04-09

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Arthritis Rheumatol：肺蛋白KL-6和CCL-18可以预测系统性硬化症间质性肺病的进展

2019-09-07

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JEM：南医大新发现罕见病多发性硬化症的一个致病蛋白

2020-01-28

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Arthritis Rheumatol：使用自身抗体和皮肤亚群建立系统性硬化症基于结局的疾病分类

2020-07-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

返老还童？——系统性硬化症

2020-03-22

科室
- - 订阅+
  - 更多科室
工具
服务